Innoprot is distributing Brindx recombinant proteins. Brindx specializes in providing protein constructs tailored for neurodegenerative disease research, focusing on fibrillar, oligomeric, and monomeric forms. Their offerings include proteins such as alpha-synuclein and tau, essential for advancing understanding and therapeutic development in this critical field.
